Buccal fentanyl may be valid option during placement of indwelling central venous access port
the ONA take:
Fentanyl buccal tablet is a valid, practical, and safe method of procedural analgesia for patients with cancer during placement of indwelling central venous access systems, a new study published online ahead of print in the journal Supportive Care in Cancer has shown.
Although local anesthesia is most commonly used to overcome pain related to the procedural placement of fully implantable venous access systems in patients with cancer, it may not eradicate all pain. Therefore, researchers sought to evaluate the effectiveness and safety of fentanyl buccal tablet in reducing procedural pain related to the placement of the port in opioid-naïve patients.
For the study, researchers enrolled 65 inpatients who required an indwelling vascular access port. Patients received a 100-mcg fentanyl buccal tablet 10 minutes before preparation of the operating field.
Results showed that nearly 94% of patients experienced no or little pain during the procedure. Only four patients reported a lot of pain, and no patients reported very severe pain.
In regard to safety, 43.1% experienced drowsiness, 9.2% experienced nausea, and 4.7% experienced vomiting, at the end of the procedure. Four hours after the procedure, the rates of drowsiness, nausea, and vomiting were 12.5%, 10.9%, and 7.8%, respectively.
“It will be necessary to perform further studies, taking into account the need for standard antiemetic premedication to [minimize] the incidence of nausea and vomiting,” the authors conclude.
Fentanyl buccal tablet is a valid, practical, and safe method of procedural analgesia for patients with cancer.
- Novel Blood Test Detects Cancer, Locates Tumor Without Invasive Procedures
- Cabozantinib Activates Innate Immune Response, Eliminating Prostate Cancer
- Shorter Treatment of Breast Cancer with Trastuzumab May Lead to Improved Results
- Colorectal Cancer Rates Increased Sharply Among Generation X and Millennials
- Pneumonia Associated With Common Cold May Cause Fatal Illness in Stem Cell Transplant Recipients
- Early Palliative Care Reduced ICU Use in Patients With Advanced Cancer
- Ginger Extract Raises Antioxidant Levels in Patients Undergoing Chemotherapy
- Nurse Navigators Improve Physician Engagement in Pretreatment Discussions
- Screening Increases Early Palliative Care, Reduces Aggressive EOL Measures
- Antiperspirants/Deodorants and Breast Cancer (Fact Sheet)
- Genome Sequencing Explains Resistance to CTLA-4 and PD-1 Inhibitors in Metastatic Melanoma
- Lifestyle Choices Have Greater Influence on Colon and Rectal Cancer Risk
- Kidney Cancer Metastases in Lung May Hide Undiagnosed Primary Lung Cancer
- Nasal Biomarker in Smokers Could Predict Lung Cancer
- Arm Lymphoscintigraphy After Axillary Lymph Node Dissection or Sentinel Lymph Node Biopsy in Breast Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|